Breast cancer decline mirrors fall in hormone use, spurs both debate and research.

Journal of the National Cancer Institute

Volumn 99, Issue 4, 2007, Pages 266-267

  McNeil, Caroline ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

AGE; AGED; ARTICLE; BREAST TUMOR; CANCER REGISTRY; CHEMICALLY INDUCED DISORDER; ESTROGEN THERAPY; FEMALE; HUMAN; INCIDENCE; MAMMOGRAPHY; MIDDLE AGED; POSTMENOPAUSE; RADIOGRAPHY; STATISTICS; UNITED STATES;

AGE FACTORS; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; INCIDENCE; MAMMOGRAPHY; MIDDLE AGED; POSTMENOPAUSE; SEER PROGRAM; SELECTIVE ESTROGEN RECEPTOR MODULATORS; UNITED STATES;

EID: 33847772506     PISSN: None     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djk088     Document Type: Article

References (0)